Ipilimumab and erythema multiforme Patient Reports February 12, 2012
Ipilimumab Side Effects Report #6086144-X
Ipilimumab side effect was reported by a Consumer or non-health professional from UNITED STATES on Feb 10, 2009. Male patient, 64 years of age, was diagnosed with lung neoplasm malignant, cardiac failure congestive, hypertension and was treated with Ipilimumab. After drug was administered, patient experienced the following side effects: confusional state, dyspnoea, erythema multiforme, hypocalcaemia, pneumonia
, pyrexia. Ipilimumab dosage: unknown. During the same period patient was treated with TAXOL, CARBOPLATIN, COREG, PIPERACILLIN, LEVOFLOXACIN, FLUCONAZOLE. Patient was hospitalized. Patient recovered.Ipilimumab Side Effects Report #6094264-9
Ipilimumab side effect was reported by a Consumer or non-health professional from UNITED STATES on Feb 20, 2009. Male patient, 64 years of age, was diagnosed with lung neoplasm malignant, cardiac failure congestive, hypertension and was treated with Ipilimumab. After drug was administered, patient experienced the following side effects: erythema multiforme, hypocalcaemia, hypoglycaemia, metabolic acidosis, pneumonia
, sepsis
. Ipilimumab dosage: unknown. During the same period patient was treated with TAXOL, CARBOPLATIN, COREG, PIPERACILLIN, LEVOFLOXACIN, FLUCONAZOLE. Patient was hospitalized. Patient died on 02/18/2009.Ipilimumab Side Effects Report #6102476-0
Ipilimumab side effect was reported by a Consumer or non-health professional from UNITED STATES on Feb 20, 2009. Male patient, 64 years of age, was diagnosed with lung neoplasm malignant, cardiac failure congestive, hypertension and was treated with Ipilimumab. After drug was administered, patient experienced the following side effects: erythema multiforme, hypocalcaemia, hypoglycaemia, metabolic acidosis, pneumonia
, sepsis
. Ipilimumab dosage: unknown. During the same period patient was treated with TAXOL, CARBOPLATIN, COREG, PIPERACILLIN, LEVOFLOXACIN, FLUCONAZOLE. Patient was hospitalized. Patient died on 02/18/2009.
Ipilimumab and erythema multiforme 